Status:

COMPLETED

Evaluation of the Safety and Usability of the MAK Exoskeleton in Patients With Stroke

Lead Sponsor:

MarsiBionics

Conditions:

Stroke

Gait, Hemiplegic

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

This study aims to evaluate the safety and usability of a motorized mobility assistance exoskeleton (MAK). The procedure explores the use of the MAK exoskeleton during the static and dynamic rehabilit...

Eligibility Criteria

Inclusion

  • Age between 18 and 85 years
  • Weight \< 100 kg
  • Height between 1.5 and 1.9 meters
  • Anthropometric measurements to fit in the exoskeleton:
  • Distance from the center of the knee joint to the ground: 42 - 55 cm
  • Distance from the center of the knee to the groin fold: more than 28 cm.
  • Perimeter in thigh (midpoint trochanter - epicondyle): 40 - 63 cm.
  • Perimeter in calf (point of greater volume): 30 - 44 cm.
  • Ability to follow simple commands and communicate basic needs
  • Presence of unilateral hemiparesis
  • Diagnosis of stroke confirmed with imaging tests.
  • Sub-acute or chronic patients (time since diagnosis 1 month or more)
  • Score on FAC scale from 1 to 4
  • Sufficient postural control to maintain standing posture and to take a step with the weight on the affected lower limb, manual assistance or technical aids being allowed

Exclusion

  • Spasticity \> 3 in lower limbs according to the MAS scale
  • Skin alterations in the contact areas with the exoskeleton
  • Planned surgical intervention during the duration of the study
  • Two or more osteoporotic fractures in the lower limbs in the last 2 years
  • Presence of other pathologies that cause exercise intolerance (such as uncontrolled hypertension, coronary artery disease, arrhythmia, congestive heart failure, Parkinson's, severe lung disease)
  • Surgical operation in the 3 months prior to the start of the study on the lower limbs

Key Trial Info

Start Date :

October 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 23 2021

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT04837144

Start Date

October 6 2020

End Date

June 23 2021

Last Update

June 24 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MarsiCare

Madrid, Arganda Del Rey, Spain, 28500